The animal gastroesophageal reflux disease market is projected to grow from USD 3.3 billion in 2025 to USD 6.9 billion by 2035, at a CAGR of 7.5%. Treatment will dominate with a 65.0% market share, while companion animals will lead the animal type segment with a 72.0% share.